Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-03

Clinical Trial Update: Safety and Efficacy of MBF-118 in Patients with Crohn Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update showing safety and efficacy signals for MBF-118 in Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MBF-118

Snippet

Sponsor: Medibiofarma S.L. | Conditions: Crohn Disease | Phase 2 | Status: COMPLETED